Blood Pressure Management in Acute Stroke. Bradley Molyneaux, M.D., Ph.D. Departments of Neurology & Critical Care Medicine University of Pittsburgh
|
|
- Lewis Tyler
- 6 years ago
- Views:
Transcription
1 Blood Pressure Management in Acute Stroke Bradley Molyneaux, M.D., Ph.D. Departments of Neurology & Critical Care Medicine University of Pittsburgh
2 80 yo M w/ R MCA syndrome NIHSS 14
3 A balancing act
4 Cerebral blood flow & ischemia Symptoms of stroke Dead brain Ischemic brain Alive, but nonfunctional Normal brain Functional ml/100g/min Courtesy Leslie-Mazwi, T.
5 Autoregulation of CBF CBF is dependent on adequate CPP CPP = MAP - CPP Chestnut RM, Ann NY Acad Sci, 2014
6 Brief periods of hypotension can severely exacerbate infarct Powers. Neurology :461-7
7 Relationship of baseline systolic BP to outcome Jo Leonardi-Bee et al. Stroke. 2002;33:
8 Vemmos KN, J Int Med, 2004
9 Non-recanalized patients Recanalized patients Ana Inês Martins et al. Stroke. 2016;47:
10 Blood pressure drops faster if recanalization Heinrich P. Mattle et al. Stroke. 2005;36:
11 Time Course of Hypertension in Acute Stroke CATIS Trial. JAMA. 2014;311(5):
12 Hyperacute management Target blood pressure by clinical scenario BP < 220/120 if no tpa BP < 185/110 prior to tpa BP < 180/105 after tpa SBP < after thrombectomy Consider trial of temporary augmentation If large vessel occlusion If any sedation
13 Antihypertensive Treatment Nicardipine Minimal cerebral vasodilatation Titratable, 5 to 15 mg/hr; q5-15mins Can result in shunt and hypoxia Clevidipine Similar to nicardipine More rapidly titratable, 2 32 mg/hr; q90 secs Caution lipid load Labetalol Bolus mg Caution longer half life Enalaprilat; Esmolol
14 Antihypertensive Treatment: other options Hydralazine Variable effects causing over correction Difficult to titrate Sodium nitroprusside effect on ICP Sodum nitroprusside Generally avoid Some risk of increased ICP Transient antiplatelet effects Anile et al 1981, Acta Neurochirurgica
15 Trials of treating acute hypertenson: CATIS PRoFESS VENTURE CHHIPS RIGHT ENOS COSSACS SCAST VENUS
16 SCAST candesartan vs placebo 2029 patients SBP > 140 Randomized w/in 30 hrs Sandset et al. Lancet ,
17 SCAST no benefit, possible harm p =0.048 Sandset et al. Lancet ,
18 ENOS transdermal glyceryl trinitrate 4011 patients SBP > 140 Randomized w/in 48 hrs Twice the BP reduction of SCAST Lancet ,
19 ENOS possible benefit if given early Investigating in RIGHT-2 200/850 enrolled Lancet ,
20 CATIS antihypertensives vs none 4071 patients SBP Randomized w/in 48 hrs CATIS Trial. JAMA. 2014;311(5):
21 CATIS antihypertensives vs none Primary Outcome mrs 3 at hospital discharge No difference (33.6%); p = patients SBP Randomized w/in 48 hrs CATIS Trial. JAMA. 2014;311(5):
22 CATIS subgroup
23 Trials of treating acute hypertenson: Meng Lee et al. Stroke. 2015;46:
24 Summary Hyperacute blood pressure by clinical scenario SBP < 220/120 if no tpa BP < 185/110 prior to tpa BP < 180/105 after tpa SBP < after thrombectomy No evidence of benefit from early PO blood pressure regimen
25 Series of trials with mixed results CHHIPS; UK 179 pts SBP>160 within 36 hrs of stroke (mean 19 hrs). Randomize to labet or placebo. No differrence between groups. COSSACS Conclusion: the study found no benefits of early continuation of antihypertensive medication after acute stroke, but it also found no substantial harms. SCAST Conclusion: when associated with large declines in systolic BP, early use of candesartan may be harmful in AIS patients. CATIS FAST MAG ENOSS
26 Trials of anti-hypertensives in acute stroke Study Stoke type n ACCESS 20 I: 100% H: 0% Mean onset time to Inclusion BP and target randomization BP reduction (hours) Mean SBP 6 24 hours after admission 200 mm Hg or DBP 110 mm Hg. Mean SBP hours after admission 180 mm Hg or DBP 105 mm Hg. Target 10 15% BP reduction within 24 hours. Drug Candesarta n Mean BP reduction in treatment group No significant reduction Stroke classification NA Functional independence and Comments cerebrovascular events No difference in Treatment Barthel Index at 3 population had months. No higher BPs than difference in other studies cerebrovascular events at 12 months PRoFESS substudy 22 I: 100% H: 0% 1, Inclusion SBP Telmisartan SBP Small-artery mm Hg and DBP 110 mm Hg reduction 6.1 occlusion: 52% mm Hg at 7 Cardioembolic: days and % mm Hg at 90 days No difference in mrs Post-hoc score at 30 days or analysis. stroke recurrence at Dysphasic 90 days patients excluded. SCAST 23 I: 85% H: 14% CHHIPS 12 I: 86% H: 14% 2, Inclusion SBP >140 mm Hg. Fixed dose-escalation schedule. No target specified. 179 Treatment: 19.8 hours Placebo: 17.4 hours Inclusion SBP >160 mm Hg. Target SBP of mm Hg or 15 mm Hg decrease at 4 hours. Candesarta n SBP reduction 5 mm Hg and DBP reduction 2 mm Hg on day 7. Lacunar infarct: 27% for candesartan, 31% for placebo No difference in mrs Dose score or stroke adjustments if recurrence at 6 SBP <120 mm months Hg or if clinically indicated Oral SBP Lacunar infarct: No difference in Treatment labetalol (50 reduction 14 28% treatment and death or dependency discontin ued if mg), oral lisinopril (5 mg), or placebo 16% placebo rate at 2 weeks between treatment and placebo SBP <140 mm Hg within 8 hours of drug administration mm Hg and DBP reduction 7 mm Hg with lisinopril at 24 hours COSSACS 25 I: 59% H: 5% hours after stroke onset and 16 hours after last dose of antihypertensiv e drug Inclusion SBP <200 mm Hg and DBP <120 mm Hg. No target reduction Continuatio n of home medications SBP reduction 13 mm Hg and DBP reduction 8 mm Hg at 2 weeks Lacunar infarct: 38% No difference in No BP death or dependency differences rate at 2 weeks. between control No difference in and treatment stroke recurrence at groups prior to 6 months 2 weeks. CATIS 26 I: 100% H: 0% 4,071 Treatment: 15.3 hours Control: 14.9 hours Inclusion SBP Predefined mm Hg. algorithm Target SBP reduction involving 10 25% at 24 hours. ACE-I, Target BP <140/90 mm CCB, and Hg at 7 days. diuretics SBP reductions 8.1 and 9.3 mm Hg, and DBP reductions 3.8 and 4.0 mm Hg at 24 hours and 7 days Lacunar infarct: treatment 20.5%, control 18.9% No difference in IV thrombolytic death or disability use in <3% of rate at 14 days after participants. randomization. No difference in mrs score at 3 months ACE-I: angiotensin-converting enzyme inhibitors, BP: blood pressure, CCB: calcium-channel blockers, DBP: diastolic BP, I: ischemic, H: hemorrhagic, mrs: modified Rankin Scale, SBP: systolic BP. McManus & Liebeskind, J Clin Neurol Apr;12(2):
BLOOD PRESSURE MANAGEMENT IN THE ACUTE PHASE
BLOOD PRESSURE MANAGEMENT IN THE ACUTE PHASE Ελένη Κορομπόκη, MD, PhD, FESO Α Νευρολογική Κλινική, ΕΚΠΑ, Αιγινήτειο Νοσοκομείο Κλινική Ερευνήτρια, Department of Stroke Medicine, Imperial College London,
More informationAcute Medical Management. Bogachan Sahin, M.D., Ph.D. Department of Neurology
Acute Medical Management Bogachan Sahin, M.D., Ph.D. Department of Neurology Outline Head-of-bed position Blood pressure management Antiplatelet therapy Anticoagulation Statin therapy Rehabilitation and
More informationBlood Pressure Management in Acute Ischemic Stroke
Blood Pressure Management in Acute Ischemic Stroke Kimberly Clark, PharmD, BCCCP Clinical Pharmacy Specialist Critical Care, Greenville Health System Adjunct Assistant Professor, South Carolina College
More informationCerebral Autoregulation What s the Big Deal? Kathy Morrison MSN, RN, CNRN Gayle Watson MSN, RN, CCNS, CCRN
Cerebral Autoregulation What s the Big Deal? Kathy Morrison MSN, RN, CNRN Gayle Watson MSN, RN, CCNS, CCRN Background 30% of patients have history of hypertension prior to stroke 80% will present with
More informationJNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults
JNC 8 2014 Evidence-Based Guidelines for the Management of High Blood Pressure in Adults Table of Contents Why Do We Treat Hypertension? Blood Pressure Treatment Goals Initial Therapy Strength of Recommendation
More informationProtocol for IV rtpa Treatment of Acute Ischemic Stroke
Protocol for IV rtpa Treatment of Acute Ischemic Stroke Acute stroke management is progressing very rapidly. Our team offers several options for acute stroke therapy, including endovascular therapy and
More informationHypertensive Crises. Controlling high blood pressure prevents disease. Recognition and Management of Acute Hypertensive Emergencies
Controlling high blood pressure prevents disease Recognition and Management of Acute Hypertensive Emergencies David idweiner, M.D. Co-holder, C. Craig and Audrae Tisher Chair in Nephrology Functional Genomics
More informationHypertensive Urgency and Emergency. Definitions. Emergency or Urgency?
Hypertensive Urgency and Emergency Joel Handler MD Kaiser Permanente Care Management Institute/ SCal Region Hypertension Lead Definitions Hypertensive Emergency: -Severe elevation in BP with evidence of
More informationHow Low Should You Go? Management of Blood Pressure in Intracranial Hemorrhage
How Low Should You Go? Management of Blood Pressure in Intracranial Hemorrhage Rachael Scott, Pharm.D. PGY2 Critical Care Pharmacy Resident Pharmacy Grand Rounds August 21, 2018 2018 MFMER slide-1 Patient
More informationManaging Hypertension in the Perioperative Arena
Managing Hypertension in the Perioperative Arena Optimizing Perioperative Management Strategies for Hypertension in the Cardiac Surgical Patient Objectives: Treatment of hypertensive emergencies. ALBERT
More informationBlood Pressure Management for Stroke Prevention and in Acute Stroke
Journal of Stroke 2017;19(2):152-165 https://doi.org/10.5853/jos.2017.00164 Review Blood Pressure Management for Stroke Prevention and in Acute Stroke Keun-Sik Hong Department of Neurology, Ilsan Paik
More informationIncidental Findings; Management of patients presenting with high BP. Phil Swales
Incidental Findings; Management of patients presenting with high BP Phil Swales Consultant Physician Acute & General Medicine University Hospitals of Leicester NHS Trust Objectives The approach to an incidental
More informationBlood Pressure Reduction Among Acute Stroke Patients A Randomized Controlled Clinical Trial
Blood Pressure Reduction Among Acute Stroke Patients A Randomized Controlled Clinical Trial Jiang He, Yonghong Zhang, Tan Xu, Weijun Tong, Shaoyan Zhang, Chung-Shiuan Chen, Qi Zhao, Jing Chen for CATIS
More informationHypertensives Emergency and Urgency
Hypertensives Emergency and Urgency Budi Yuli Setianto Cardiology Divisision Department of Internal Medicine Faculty of Medicine UGM Sardjito Hospital Yogyakarta Background USA: Hypertension is 30% of
More informationHYPERTENSION IN EMERGENCY MEDICINE Michael Jay Bresler, M.D., FACEP
HYPERTENSION IN EMERGENCY MEDICINE Michael Jay Bresler, M.D., FACEP What is normal blood pressure? Prehypertension 130-139/80-90 Compared with normal BP Double the risk for developing hypertension. Lifestyle
More information11/23/2015. Disclosures. Stroke Management in the Neurocritical Care Unit. Karel Fuentes MD Medical Director of Neurocritical Care.
Stroke Management in the Neurocritical Care Unit Karel Fuentes MD Medical Director of Neurocritical Care Disclosures I have no relevant commercial relationships to disclose, and my presentations will not
More informationHemorrhage. Dr. Al Jin Nov. 17, 2015
Hemorrhage Dr. Al Jin Nov. 17, 2015 None Disclosures ICH Management in ER ABCs Treat hypertension What BP target? Reverse warfarin Hemorrhage vs Ischemic Stroke Lowering BP may be harmful in ischemic stroke
More information5/2/2016. Outpatient Stroke Management Sheila Smith MD May 5, 2016
Outpatient Stroke Management Sheila Smith MD May 5, 2016 1 Management of Outpatient Stroke Objectives Review blood pressure management post stroke Review antithrombotic therapy Review statin therapy Discuss
More information11/27/2017. Stroke Management in the Neurocritical Care Unit. Conflict of interest. Karel Fuentes MD Medical Director of Neurocritical Care
Stroke Management in the Neurocritical Care Unit Karel Fuentes MD Medical Director of Neurocritical Care Conflict of interest None Introduction Reperfusion therapy remains the mainstay in the treatment
More informationReview Article Unsolved Issues in the Management of High Blood Pressure in Acute Ischemic Stroke
International Hypertension Volume 2013, Article ID 349782, 5 pages http://dx.doi.org/10.1155/2013/349782 Review Article Unsolved Issues in the Management of High Blood Pressure in Acute Ischemic Stroke
More informationMANAGEMENT OF HYPERTENSION IN PREGNANCY, THE ALGORHITHM
MANAGEMENT OF HYPERTENSION IN PREGNANCY, THE ALGORHITHM Are Particular Anti-hypertensives More Effective or Harmful Than Others in Hypertension in Pregnancy? Existing data is inadequate Methyldopa and
More informationDisclosures. Anesthesia for Endovascular Treatment of Acute Ischemic Stroke. Acute Ischemic Stroke. Acute Stroke = Medical Emergency!
Disclosures Anesthesia for Endovascular Treatment of Acute Ischemic Stroke I have nothing to disclose. Chanhung Lee MD, PhD Associate Professor Anesthesia and perioperative Care Acute Ischemic Stroke 780,000
More informationNURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACUTE CEREBROVASCULAR ACCIDENT TPA (ACTIVASE /alteplase) FOR THROMBOLYSIS
NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS ACUTE CEREBROVASCULAR ACCIDENT TPA (ACTIVASE /alteplase) FOR THROMBOLYSIS I. Purpose : A. To reduce morbidity and mortality associated
More informationHypertension (JNC-8)
Hypertension (JNC-8) Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 17, 2018, presented by Ezra Levy, Pharm.D.! The 8 th Joint
More informationAntihypertensive Trial Design ALLHAT
1 U.S. Department of Health and Human Services Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic National Institutes
More informationTony L Smith DNP RN ACNP CCRN CFRN EMT-IV Vanderbilt LifeFlight
Treatment of a Stroke patient: A look at how to care for the Stroke patient in the aeromedical setting Tony L Smith DNP RN ACNP CCRN CFRN EMT-IV Vanderbilt LifeFlight Objectives 1. Discuss the assessment
More informationVA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005
VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 1 Any adult in the health care system 2 Obtain blood pressure (BP) (Reliable,
More informationKlinikum Frankfurt Höchst
Blood pressure management in hemorrhagic stroke Blood pressure in acute ICH Do we need additional trials after INTERACT2 and ATTACH-II? Focus.de Department of Neurology,, Germany Department of Neurology,
More informationCritical Care Management of Acute Ischemic Stroke
Critical Care Management of Acute Ischemic Stroke Gene Sung, M.D., M.P.H. Past-President, Neurocritical Care Society Neurocritical Care and Stroke Division University of Southern California USC Stroke
More informationDawn Matherne Meyer PhD,RN,FNP-C. Assistant Professor University of California San Diego
Dawn Matherne Meyer PhD,RN,FNP-C Assistant Professor University of California San Diego Evidence Based Care of the Stroke Patient: A Focus on Acute Treatment, BP Management, & Antiplatelets TIME IS BRAIN
More informationArticles. Funding UK Medical Research Council. Copyright Bath et al. Open Access article distributed under the terms of CC BY.
Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial The ENOS Trial
More informationALLHAT. Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic
1 U.S. Department of Health and Human Services National Institutes of Health Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker
More information2018 Early Management of Acute Ischemic Stroke Guidelines Update
2018 Early Management of Acute Ischemic Stroke Guidelines Update Brandi Bowman, PhC, Pharm.D. April 17, 2018 Pharmacist Objectives Describe the recommendations for emergency medical services and hospital
More informationDISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose.
JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES Tiffany Dickey, PharmD Assistant Professor, UAMS COP Clinical Pharmacy Specialist, Mercy Hospital Northwest AR DISCLOSURE I
More informationStroke Guidelines. November 19, 2011
Stroke Guidelines November 19, 2011 Clinical Practice Guidelines American Stroke Association Guidelines are comprehensive statements that provide the highest level of scientific evidence for clinical practice.
More informationBlood pressure changes in acute ischemic stroke and outcome with respect to stroke etiology
Blood pressure changes in acute ischemic stroke and outcome with respect to stroke etiology G. Ntaios, MD D. Lambrou, PhD P. Michel, MD Correspondence & reprint requests to Dr. Ntaios: gntaios@med.uth.gr
More informationUnclogging The Pipes. Zahraa Rabeeah MD Chief Resident February 9,2018
Unclogging The Pipes Zahraa Rabeeah MD Chief Resident February 9,2018 Please join Polleverywhere by texting: ZRABEEAH894 to 37607 Disclosures None Objectives Delineate the differences between TPA vs thrombectomy
More informationMODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure. No relevant financial relationships. Blood Pressure and Risk
MODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure No relevant financial relationships Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine baron@medicine.ucsf.edu
More informationTop 5 Big Things in Acute Stroke Care! Raymond W. Grams II, DO Vascular Neurology Stroke Medical Director DRMC, Intermountain Healthcare
Top 5 Big Things in Acute Stroke Care! Raymond W. Grams II, DO Vascular Neurology Stroke Medical Director DRMC, Intermountain Healthcare Late Time Window Endovascular Trials 48.6% WITH intervention vs
More informationHypertensive Haemorrhagic Stroke. Dr Philip Lam Thuon Mine
Hypertensive Haemorrhagic Stroke Dr Philip Lam Thuon Mine Intracerebral Haemorrhage Primary ICH Spontaneous rupture of small vessels damaged by HBP Basal ganglia, thalamus, pons and cerebellum Amyloid
More informationLong-Term Care Updates
Long-Term Care Updates August 2015 By Darren Hein, PharmD Hypertension is a clinical condition in which the force of blood pushing on the arteries is higher than normal. This increases the risk for heart
More informationACUTE STROKE MANAGEMENT
ACUTE STROKE MANAGEMENT. Before the Specialist Arrives C A R L O S L C H U A, M D, F P N A UP- P H I L I P P I N E G E N E R A L H O S P I T A L P R E S I D E N T, S T R O K E S O C I E T Y O F T H E P
More informationParameter Optimized Treatment for Acute Ischemic Stroke
Heart & Stroke Barnett Memorial Lectureship and Visiting Professorship Parameter Optimized Treatment for Acute Ischemic Stroke December 2, 2016, Thunder Bay, Ontario Adnan I. Qureshi MD Professor of Neurology,
More informationSTANDARD treatment algorithm mmHg
STANDARD treatment algorithm 130-140mmHg (i) At BASELINE, If AVERAGE SBP 1 > 140mmHg If on no antihypertensive drugs: Start 1 drug: If >55 years old / Afro-Caribbean: Calcium channel blocker (CCB) 2 If
More informationAcute Stroke Care: the Nuts and Bolts of it. ECASS I and II ATLANTIS. Chris V. Fanale, MD Colorado Neurological Institute Swedish Medical Center
Acute Stroke Care: the Nuts and Bolts of it Chris V. Fanale, MD Colorado Neurological Institute Swedish Medical Center ECASS I and II tpa for patients presenting
More informationStroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14%
Stroke Update Michel Torbey, MD, MPH, FAHA, FNCS Medical Director, Neurovascular Stroke Center Professor Department of Neurology and Neurosurgery The Ohio State University Wexner Medical Center Objectives
More informationJournal Club. 1. Develop a PICO (Population, Intervention, Comparison, Outcome) question for this study
Journal Club Articles for Discussion Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-pa Stroke Study Group. N Engl J Med. 1995 Dec
More informationManaging Hypertension in 2016
Managing Hypertension in 2016: Where Do We Draw the Line? Disclosure No relevant financial relationships Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine baron@medicine.ucsf.edu
More informationInt. J. Pharm. Sci. Rev. Res., 36(1), January February 2016; Article No. 06, Pages: JNC 8 versus JNC 7 Understanding the Evidences
Research Article JNC 8 versus JNC 7 Understanding the Evidences Anns Clara Joseph, Karthik MS, Sivasakthi R, Venkatanarayanan R, Sam Johnson Udaya Chander J* RVS College of Pharmaceutical Sciences, Coimbatore,
More informationMetoprolol Succinate SelokenZOC
Metoprolol Succinate SelokenZOC Blood Pressure Control and Far Beyond Mohamed Abdel Ghany World Health Organization - Noncommunicable Diseases (NCD) Country Profiles, 2014. 1 Death Rates From Ischemic
More informationHypertension. Does it Matter What Medications We Use? Nishant K. Sekaran, M.D. M.Sc. Intermountain Heart Institute
Hypertension Does it Matter What Medications We Use? Nishant K. Sekaran, M.D. M.Sc. Intermountain Heart Institute Hypertension 2017 Classification BP Category Systolic Diastolic Normal 120 and 80 Elevated
More informationBY: Ramon Medina EMT-LP/RN
BY: Ramon Medina EMT-LP/RN Discuss types of strokes Discuss the physical and neurological assessment of stroke patients Discuss pertinent historical findings Discuss pre-hospital and emergency management
More informationFact. Fact. Purpose. Role of BP in stroke Management of BP in acute ischemic stroke patients JIKEI Heart study: Personal views. Conflict of interest
JIKEI Satellite Meeting New Evidence in Management of High Risk Hypertension in Asian Population : Roles of ARB Can We Prevent Stroke for High Risk Hypertension Patients Beyond BP Reduction Associate Professor
More informationDuring the first few hours of ischemic stroke, a high blood
Effects of Blood Pressure and Blood Pressure Lowering Treatment During the First 24 Hours Among Patients in the Third International Stroke Trial of Thrombolytic Treatment for Acute Ischemic Stroke Eivind
More informationPrevention and Management of hypertensive stroke. Content. What are the clinical and radiological manifestations for HT-related stroke?
Prevention and Management of hypertensive stroke Dr. LO, Man-wai MBChB (CUHK) MRCP (UK) MPH (CUHK) FHKCP FHKAM (Medicine) Specialist in Neurology Dept. of Medicine Queen Elizabeth Hospital 4 Dec 2006 Content
More informationENCHANTED Era: Is it time to rethink treatment of acute ischemic stroke? Kristin J. Scherber, PharmD, BCPS Emergency Medicine Clinical Pharmacist
ENCHANTED Era: Is it time to rethink treatment of acute ischemic stroke? Kristin J. Scherber, PharmD, BCPS Emergency Medicine Clinical Pharmacist Pharmacy Grand Rounds 26 July 2016 2015 MFMER slide-1 Learning
More informationBLOOD PRESSURE VARIABILITY AND STROKE ADAM DE HAVENON, MD UNIVERSITY OF UTAH
BLOOD PRESSURE VARIABILITY AND STROKE ADAM DE HAVENON, MD UNIVERSITY OF UTAH OBJECTIVES Why blood pressure variability (BPV)? Measurement of BPV Association with outcome after stroke Association with incident
More informationVariability in Blood Pressure Medications Prescribed to Stroke Patients at Hospital Discharge
Variability in Blood Pressure Medications Prescribed to Stroke Patients at Hospital Discharge A. Lantzy, MSN, RN, L. Simo, A. Carlson-Chalifoux, MS, RN, AGACNP-BC, CCRN, SCRN, P. Feit, MS, A. Sharrief,
More informationImpact of Resting Heart Rate on Mortality, Disability and Cognitive Decline in Patients after Ischemic Stroke
Impact of Resting Heart Rate on Mortality, Disability and Cognitive Decline in Patients after Ischemic Stroke Data from PROFESS M. Böhm Daniel Cotton, Lydia Foster, Florian Custodis, Ulrich Laufs, Ralph
More informationUpdate on Current Trends in Hypertension Management
Friday General Session Update on Current Trends in Hypertension Management Shawna Nesbitt, MD Associate Dean, Minority Student Affairs Associate Professor, Department of Internal Medicine Office of Student
More informationSBP in range of 120 to 140 :no progression or regression of CAD. Sipahi et al., 2006
Management of Hypertension in Patients with CAD M. Mohsen Ibrahim, MD Cardiology Department- Cairo University 1. What is the optimal BP in patients with hypertension and CAD? 2. What is the minimum safe
More informationNational Collaborating Centre for Chronic Conditions at the Royal College of Physicians
13. Surgery for acute stroke 13.2 Surgical referral for decompressive hemicraniectomy Reference Gupta R, Connolly ES, Mayer S et al. Hemicraniectomy for massive middle cerebral artery territory infarction:
More informationSupplementary Online Content
Supplementary Online Content Xu X, Qin X, Li Y, et al. Efficacy of folic acid therapy on the progression of chronic kidney disease: the Renal Substudy of the China Stroke Primary Prevention Trial. JAMA
More informationImaging Stroke: Is There a Stroke Equivalent of the ECG? Albert J. Yoo, MD Director of Acute Stroke Intervention Massachusetts General Hospital
Imaging Stroke: Is There a Stroke Equivalent of the ECG? Albert J. Yoo, MD Director of Acute Stroke Intervention Massachusetts General Hospital Disclosures Penumbra, Inc. research grant (significant) for
More informationStroke Update Elaine J. Skalabrin MD Medical Director and Neurohospitalist Sacred Heart Medical Center Stroke Center
Stroke Update 2015 Elaine J. Skalabrin MD Medical Director and Neurohospitalist Sacred Heart Medical Center Stroke Center Objectives 1. Review successes in systems of care approach to acute ischemic stroke
More informationClinical Study Effect of Telmisartan on Cerebral and Systemic Haemodynamics in Patients with Recent Ischaemic Stroke: A Randomised Controlled Trial
ISRN Stroke Volume 2013, Article ID 587954, 9 pages http://dx.doi.org/10.1155/2013/587954 Clinical Study Effect of Telmisartan on Cerebral and Systemic Haemodynamics in Patients with Recent Ischaemic Stroke:
More informationADVANCES IN MANAGEMENT OF HYPERTENSION
Prevalence 29%; Blacks 33.5% About 72.5% treated; 53.5% uncontrolled (>140/90) Risk for poor control: Latinos, Blacks, age 18-44 and 80,
More informationBLOOD PRESSURE-LOWERING TREATMENT
BLOOD PRESSURE-LOWERING TRIALS NUMBER OF PARTICIPANTS NUMBER OF PERCENTAGE OF MEAN AGE MEAN - (YEARS) TRIALS WITH ANALYSIS BY GENDER N, (%) 69,473 28,008 40.3% 70.2 3.2 3/5 (60%) APPENDIX 2 1 BLOOD PRESSURE-LOWERING
More informationAcute Stroke Treatment Update for 2008
Acute Stroke Treatment Update for 2008 * Michael R. Dobbs, MD Assistant Professor of Neurology, Preventive Medicine, and Graduate Center for Toxicology University of Kentucky College of Medicine The Stroke
More informationGUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE
2018 UPDATE QUICK SHEET 2018 American Heart Association GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE A Summary for Healthcare Professionals from the American Heart Association/American
More informationReview Article Elevated Blood Pressure in the Acute Phase of Stroke and the Role of Angiotensin Receptor Blockers
International Hypertension Volume 2013, Article ID 941783, 8 pages http://dx.doi.org/10.1155/2013/941783 Review Article Elevated Blood Pressure in the Acute Phase of Stroke and the Role of Angiotensin
More informationHYPERTENSION. Background for understanding the Hypertension literature. Case presentation. Approach to Treatment. Jeffrey J. Kaufhold, MD Nephrology
HYPERTENSION Background for understanding the Hypertension literature. Case presentation Approach to Treatment Jeffrey J. Kaufhold, MD Nephrology 2009 HYPERTENSION SUMMARY Background for understanding
More informationNIHSS. Category Scale Definition Date/Time Date/Time Date/Time. Score Initial. Drip & Ship Protocol. Initials: Signature: Initials: Signature:
NIHSS 1a. Level of Consciousness (Alert, drowsy, etc.) Category Scale Definition Date/Time Date/Time Date/Time 1b. LOC Question (Month, age) 1c. LOC Commands (Open, close eyes, make fist, let go) 2. Best
More informationThe Latest Generation of Clinical
The Latest Generation of Clinical Guidelines: HTN and HLD Dave Brackett Clinical Guideline Purpose Uniform approach Awareness of key details Diagnosis Treatment Monitoring Evidence based approach Inform
More informationHypertension Update Clinical Controversies Regarding Age and Race
Hypertension Update Clinical Controversies Regarding Age and Race Allison Helmer, PharmD, BCACP Assistant Clinical Professor Auburn University Harrison School of Pharmacy July 22, 2017 DISCLOSURE/CONFLICT
More informationCEREBROVASCULAR ACCIDENT (CVA)
Manual: LifeLine Patient Care Protocols Section: Adult/Pediatrics Protocol #: AP5-002 Approval Date: 12/01/2017 Effective Date: 12/01/2017 Revision Due Date: 12/01/2018 CEREBROVASCULAR ACCIDENT (CVA) PURPOSE
More informationHypertension and Stroke: new data
Hypertension and Stroke: new data Antonio Coca, MD, PhD, FRCP Hypertension Unit. Institute of Internal Medicine and Dermatology. Hospital Clínic (IDIBAPS). University of Barcelona, Spain WG Seminars. Hellenic
More informationUsing the New Hypertension Guidelines
Using the New Hypertension Guidelines Kamal Henderson, MD Department of Cardiology, Preventive Medicine, University of North Carolina School of Medicine Kotchen TA. Historical trends and milestones in
More informationData Fact Sheet. Congestive Heart Failure in the United States: A New Epidemic
National Heart, Lung, and Blood Institute Data Fact Sheet Congestive Heart Failure National Heart, Lung, and Blood Institute National Institutes of Health Data Fact Sheet Congestive Heart Failure in the
More informationSection 3, Lecture 2
59-291 Section 3, Lecture 2 Diuretics: -increase in Na + excretion (naturesis) Thiazide and Related diuretics -decreased PVR due to decreases muscle contraction -an economical and effective treatment -protect
More informationEndovascular Treatment of Ischemic Stroke
Endovascular Treatment of Ischemic Stroke William Thorell, MD Associate Professor Neurosurgery UNMC Co-Director Stroke and Neurovascular Center Nebraska Medicine Overview Definitions of terms Review basic
More informationADVANCES IN MANAGEMENT OF HYPERTENSION
Advances in Management of Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Current Status of Prevalence 29%; Blacks 33.5%
More informationTodd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM
Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM Faculty Disclosure I have no financial interest to disclose No off-label use of medications will be discussed FIFTH ANNUAL SYMPOSIUM Recognize changes between
More informationAntihypertensive Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia
Antihypertensive Agents Part-2 Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Agents that block production or action of angiotensin Angiotensin-converting
More informationManagement of Hypertension in special groups. DR-Mohammed Salah Assistant Lecturer of Cardiology Mansoura University
Management of Hypertension in special groups BY DR-Mohammed Salah Assistant Lecturer of Cardiology Mansoura University AGENDA SPECIAL GROUPS SPECIFIC DRUDS FOR SPECIAL GROUPS TARGET BP FOR SPECIAL GROUPS:
More informationClinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8. Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital
Clinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8 Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital Objectives Review the Eighth Joint National Committee (JNC
More informationThe Multi arm Optimization of Stroke Thrombolysis (MOST) Trial
The Multi arm Optimization of Stroke Thrombolysis (MOST) Trial Study Team Principal Investigators: Opeolu Adeoye, University of Cincinnati (Lead) Andrew Barreto, University of Texas Houston Jim Grotta,
More informationControlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial
Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial John F Potter, Thompson G Robinson, Gary A Ford, Amit Mistri, Martin
More informationEndovascular Treatment for Acute Ischemic Stroke
ular Treatment for Acute Ischemic Stroke Vishal B. Jani MD Assistant Professor Interventional Neurology, Division of Department of Neurology. Creighton University/ CHI health Omaha NE Disclosure None 1
More informationHYPERTENSION GUIDELINES WHERE ARE WE IN 2014
HYPERTENSION GUIDELINES WHERE ARE WE IN 2014 Donald J. DiPette MD FACP Special Assistant to the Provost for Health Affairs Distinguished Health Sciences Professor University of South Carolina University
More informationDISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE
ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE DISCLOSURES Editor-in-Chief- Nephrology- UpToDate- (Wolters Klewer) Richard J. Glassock, MD, MACP Geffen School of Medicine at UCLA 1 st Annual Internal
More information김광일 서울대학교의과대학내과학교실 분당서울대학교병원내과
치매예방을위한만성질환관리전략 김광일 서울대학교의과대학내과학교실 분당서울대학교병원내과 A sharp rise in the death rate from Alzheimer s disease Ivan Casserly & Eric Topol, Lancet 2004 Potential for primary prevention of Alzheimer s disease Alzheimer
More informationHypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B)
Practice Guidelines and Principles: Guidelines and principles are intended to be flexible. They serve as reference points or recommendations, not rigid criteria. Guidelines and principles should be followed
More informationManagement of Lipid Disorders and Hypertension: Implications of the New Guidelines
Management of Lipid Disorders and Hypertension Management of Lipid Disorders and Hypertension: Implications of the New Guidelines Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine
More informationPractical Considerations in the Early Treatment of Acute Stroke
Practical Considerations in the Early Treatment of Acute Stroke Matthew E. Fink, MD Neurologist-in-Chief Weill Cornell Medical College New York-Presbyterian Hospital mfink@med.cornell.edu Disclosures Consultant
More informationManagement of Hypertension
Clinical Practice Guidelines Management of Hypertension Definition and classification of blood pressure levels (mmhg) Category Systolic Diastolic Normal
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. ACE Inhibitor and Angiotensin II Antagonist Combination Treatment GUIDELINES
ACE Inhibitor and Angiotensin II Antagonist Combination Treatment Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES No recommendations possible based on Level
More information4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?
HYPERTENSION TARGETS: WHAT DO WE DO NOW? MICHAEL LEFEVRE, MD, MSPH PROFESSOR AND VICE CHAIR DEPARTMENT OF FAMILY AND COMMUNITY MEDICINE UNIVERSITY OF MISSOURI 4/4/17 DISCLOSURE: MEMBER OF THE JNC 8 PANEL
More information